Moneycontrol PRO
Upcoming Event:Attend Algo Convention Live, 2 Days & 12+ Speakers at best offer Rs.999/-, exclusive for Moneycontrol Pro subscribers. Register now!
you are here: HomeNewsBusiness

Johnson & Johnson decides not to conduct trials in India for its COVID-19 vaccine

While J&J had sought approval for conducting bridging trials in the country, the U.S.-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement, according to the report.

June 29, 2021 / 10:43 AM IST
Johnson & Johnson. | Representative Image (PC-Reuters)

Johnson & Johnson. | Representative Image (PC-Reuters)

Johnson & Johnson will not will not be undertaking local trials for its single-shot COVID-19 vaccine in India, the Economic Times reported on Tuesday, citing a company spokesperson.

While J&J had sought approval for conducting bridging trials in the country, the U.S.-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement, according to the report.

The company is exploring how to accelerate the availability of its vaccine in India, the Economic Times said.

J&J did not immediately respond to a Reuters request for comment.



Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes

Reuters
first published: Jun 29, 2021 10:28 am
Sections
ISO 27001 - BSI Assurance Mark